These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33358412)

  • 21. Primary treatment of nasolacrimal duct obstruction with probing in children younger than 4 years.
    ; Repka MX; Chandler DL; Beck RW; Crouch ER; Donahue S; Holmes JM; Lee K; Melia M; Quinn GE; Sala NA; Schloff S; Silbert DI; Wallace DK
    Ophthalmology; 2008 Mar; 115(3):577-584.e3. PubMed ID: 17996306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systematic review of endoscopic-assisted surgical management for congenital nasolacrimal duct obstruction.
    Trott S; Colgrove N; Westgate P; Bush M; Iverson K
    Int J Pediatr Otorhinolaryngol; 2020 Dec; 139():110448. PubMed ID: 33091808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Probing in Congenital Nasolacrimal Duct Obstruction in Children Older Than 2 Years.
    Une VL; Kulkarni SS; Nandedkar VS
    J Pediatr Ophthalmol Strabismus; 2019 May; 56(3):141-145. PubMed ID: 31116859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Success rates of dacryoendoscopy-guided probing for recalcitrant congenital nasolacrimal duct obstruction.
    Fujimoto M; Ogino K; Matsuyama H; Miyazaki C
    Jpn J Ophthalmol; 2016 Jul; 60(4):274-9. PubMed ID: 27116947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Case Series of Dacryoendoscopy in Childhood: A Diagnostic and Therapeutic Alternative for Complex Congenital Nasolacrimal Duct Obstruction Even in the First Year of Life.
    Heichel J; Struck HG; Fiorentzis M; Hammer T; Bredehorn-Mayr T
    Adv Ther; 2017 May; 34(5):1221-1232. PubMed ID: 28341931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Probing for congenital nasolacrimal duct obstruction in older children.
    Eshragi B; Fard MA; Masomian B; Akbari M
    Middle East Afr J Ophthalmol; 2013; 20(4):349-52. PubMed ID: 24339688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of congenital nasolacrimal duct obstruction--latin american study.
    Schellini SA; Ariki CT; Sousa RL; Weil D; Padovani CR
    Ophthalmic Plast Reconstr Surg; 2013; 29(5):389-92. PubMed ID: 23924988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of Congenital Nasolacrimal Duct Obstruction with Probing, Experience in a Mexican Eye Center.
    Zuazo F; Morales OO; Tovilla ML; Castañeda ÁN
    Nepal J Ophthalmol; 2019 Jul; 11(22):189-196. PubMed ID: 32792696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Comparison of Endonasal Dacryocystorhinostomy and External Dacryocystorhinostomy: A Report by the American Academy of Ophthalmology.
    Sobel RK; Aakalu VK; Wladis EJ; Bilyk JR; Yen MT; Mawn LA
    Ophthalmology; 2019 Nov; 126(11):1580-1585. PubMed ID: 31358391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of treatment modalities and prognostic factors in children with congenital nasolacrimal duct obstruction.
    Al-Faky YH; Al-Sobaie N; Mousa A; Al-Odan H; Al-Huthail R; Osman E; Al-Mosallam AR
    J AAPOS; 2012 Feb; 16(1):53-7. PubMed ID: 22370666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spontaneous Resolution and Timing of Intervention in Congenital Nasolacrimal Duct Obstruction.
    Sathiamoorthi S; Frank RD; Mohney BG
    JAMA Ophthalmol; 2018 Nov; 136(11):1281-1286. PubMed ID: 30178001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Probing for nasolacrimal duct obstruction with intravenous propofol sedation.
    Movaghar M; Kodsi S; Merola C; Doyle J
    J AAPOS; 2000 Jun; 4(3):179-82. PubMed ID: 10849396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nasolacrimal Duct Probing for Young Children With Congenital Nasolacrimal Duct Obstructions in China: A 10-Year Systematic Review.
    Xiang Q; Gao X; Chen X; Qi J; Fang J
    J Pediatr Ophthalmol Strabismus; 2019 Nov; 56(6):365-372. PubMed ID: 31743404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unlocking the secrets of success in probing for congenital nasolacrimal duct obstruction: investigating the factors that matter.
    Kocabas S; Oklar M; Ozturk Y; Rodop Ozgur O
    Int Ophthalmol; 2024 May; 44(1):221. PubMed ID: 38717720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors Associated With Nasolacrimal Duct Probing Failure Among Children in the Intelligent Research in Sight Registry.
    Oke I; Elze T; Miller JW; Lorch AC; Hunter DG; Elliott AT;
    JAMA Ophthalmol; 2023 Apr; 141(4):342-348. PubMed ID: 36862386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Congenital nasolacrimal duct obstruction: therapeutic management.
    Chiesi C; Guerra R; Longanesi L; Fornaciari M; Morano RP
    J Pediatr Ophthalmol Strabismus; 1999; 36(6):326-30. PubMed ID: 11132664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paediatric endoscopic endonasal dacryocystorhinostomy in congenital nasolacrimal duct obstruction.
    Leibovitch I; Selva D; Tsirbas A; Greenrod E; Pater J; Wormald PJ
    Graefes Arch Clin Exp Ophthalmol; 2006 Oct; 244(10):1250-4. PubMed ID: 16538447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resolution of congenital nasolacrimal duct obstruction with nonsurgical management.
    Pediatric Eye Disease Investigator Group
    Arch Ophthalmol; 2012 Jun; 130(6):730-4. PubMed ID: 22801833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Congenital nasolacrimal duct obstruction: irrigation or probing?
    Kim YS; Moon SC; Yoo KW
    Korean J Ophthalmol; 2000 Dec; 14(2):90-6. PubMed ID: 11213741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Congenital nasolacrimal duct obstruction: natural history and the timing of optimal intervention.
    Paul TO; Shepherd R
    J Pediatr Ophthalmol Strabismus; 1994; 31(6):362-7. PubMed ID: 7714699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.